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Abstract
IMPORTANCE The first 1000 days of life represent a critical window for child development.
Pregnancy, exclusive breastfeeding (EBF) period (0-6months), and complementary feeding (CF)
period (6-24months) have different growth requirements, so separate considerations for
intervention strategies are needed. No synthesis to date has attempted to quantify the associations
of interventions under multiple domains of micronutrient and balanced energy protein and food
supplements, deworming, maternal education, water sanitation, and hygiene across these 3 life
periods with birth and growth outcomes.
OBJECTIVE To determine themagnitude of association of interventions with birth and growth
outcomes based on randomized clinical trials (RCTs) conducted in low-income and middle-income
countries (LMICs) using Bayesian network meta-analyses.
DATA SOURCES MEDLINE, Embase, and Cochrane databases were searched from their inception up
to August 14, 2018.
STUDY SELECTION Included were LMIC-based RCTs of interventions provided to pregnant women,
infants (0-6months), and children (6-24months).
DATA EXTRACTIONAND SYNTHESIS Two independent reviewers used a standardized data
extraction and quality assessment form. Random-effects networkmeta-analyses were performed for
each life period. Effect sizes are reported as odds ratios (ORs) andmean differences (MeanDiffs) for
dichotomous and continuous outcomes, with 95% credible intervals (CrIs). This study calculated
probabilities of interventions being superior to standard of care by at least a minimal clinically
important difference.
MAINOUTCOMES ANDMEASURES The study compared ORs on preterm birth andMeanDiffs on
birth weight for pregnancy, length for age (LAZ) for EBF, and height for age (HAZ) for CF.
RESULTS Among 302061 participants in 169 randomized clinical trials, the network meta-analyses
found several nutritional interventions that demonstrated greater association with improved birth
and growth outcomes compared with standard of care. For instance, compared with standard of
care, maternal supplements of multiple micronutrients showed reduced odds for preterm birth (OR,
0.54; 95% CrI, 0.27-0.97) and improvedmean birth weight (MeanDiff, 0.08 kg; 95% CrI, 0.00-0.17
kg) but not LAZ during EBF (MeanDiff, −0.02; 95% CrI, −0.18 to 0.14). Supplementing infants and
children with multiple micronutrients showed improved LAZ (MeanDiff, 0.20; 95% CrI, 0.03-0.35)
and HAZ (MeanDiff, 0.14; 95% CrI, 0.02-0.25). The study found that pregnancy interventions
(continued)
Key Points
Question Which interventions under
the domains of nutrition, deworming,
maternal education, and water,
sanitation, and hygiene can improve
birth and linear growth outcomes during
the first 1000days of life in low-income
andmiddle-income countries (LMICs)?
Findings This study used Bayesian
network meta-analyses of 169
randomized clinical trials including
302061 participants and showed that
several nutritional interventions
demonstrating greater associations with
improved outcomes compared with
standard of care, while other domains
generally did not. Interventions
provided to pregnant women generally
demonstrated greater associations with
improved outcomes than interventions
provided to infants and children at
later periods.
Meaning The study findings suggest
that it is important to intervene early for
child development in LMICs, during
pregnancy if possible, and combine
interventions frommultiple domains
and test for their effectiveness.
+ Supplemental content
Author affiliations and article information are
listed at the end of this article.
Open Access. This is an open access article distributed under the terms of the CC-BY License.
JAMA Network Open. 2019;2(7):e197871. doi:10.1001/jamanetworkopen.2019.7871 (Reprinted) July 26, 2019 1/17
Downloaded From: https://jamanetwork.com/ by a University of Dundee User  on 07/31/2019
Abstract (continued)
generally had higher probabilities of aminimal clinically importance difference than the interventions
for the EBF or CF in the first 1000 days of life.
CONCLUSIONS ANDRELEVANCE These analyses highlight the importance of intervening early for
child development, during pregnancy if possible. Results of this study suggest that there is a need
to combine interventions frommultiple domains and test for their effectiveness as a package.
JAMA Network Open. 2019;2(7):e197871. doi:10.1001/jamanetworkopen.2019.7871
Introduction
Between 1990 and 2015, remarkable progress was made toward theMillennium Development Goals
of reducing childhoodmorbidity andmortality.1 However, childhood stunting, defined as a height for
age (HAZ) score of less than 2 SDs below the World Health Organization (WHO) Child Growth
Standards median,2 continues to be a critical public health issue, particularly in low-income and
middle-income countries (LMICs).3-5 In 2017, it was estimated that 22.2% of all children under the
age of 5 years had stunted development, with most of the burden shouldered by Asian (55%) and
African (39%) countries.6
Childhood stunting can have immediate and long-lasting negative consequences on both
physical growth and neurodevelopment.3 Immediate consequences include decreased survival
during infancy and greater childhood susceptibility to frequent infections.4,7-9 Further
developmental deficits can include sensory, motor, cognitive, language, socioemotional, cultural, and
behavioral impairments. These health and developmental issues can hamper personal, educational,
and professional attainment.4,7,8,10,11
The first 1000 days of life, a period spanning from conception to a child’s second birthday, are
critical for child development.8,12,13 This window also represents a key opportunity for stunting
intervention delivery because stunting frequently begins during this time.13 The first 1000 days of life
are often further divided into the following 3 key periods: pregnancy, the exclusive breastfeeding
(EBF) period (0-6months of age), and the complementary feeding (CF) period (6-24months of
age).14 Each of these periods deserves separate consideration with regard to the delivery of stunting
interventions because growth determinants and requirements between them differ greatly.14
Over the last decade, several review articles of clinical trials or observational studies have
rigorously investigated the consequences of interventions addressing stunting. However, all of these
focused on a single class of interventions or investigated within a single early-life period (eTable 1 in
the Supplement).12 Similarly, comprehensive reviews have been limited to summarizing key findings
of more focused review articles.11,12 No synthesis to date has attempted to summarize and quantify
the effectiveness of multiple classes of interventions across the 3 key early-life periods of pregnancy,
EBF, and CF.
Network meta-analysis is an extension of conventional pairwise meta-analysis that allows for
the comparison of interventions that have not been compared directly in head-to-head randomized
clinical trials (RCTs).15 This article uses a systematic review and network meta-analysis approach to
investigate the magnitude of association of interventions with reduced adverse birth outcomes and
improved linear growth in LMICs. We applied this approach separately to each of the 3 life periods to
determine the consequences of interventions classified as either micronutrients, balanced energy
protein or food supplements, deworming, maternal education, or water, sanitation, and hygiene
(WASH) interventions. In this article, we report themagnitude of associations of the above
interventions with birth outcomes and linear growth outcomes in the 3 key life periods across the
first 1000 days of life.
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Methods
We conducted this study according to the Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) extension to networkmeta-analysis16 and report this study according to the
JAMA users’ guides on networkmeta-analysis.17 The systematic reviews and NMAs conducted for this
study were registered in PROSPERO.18-20
Search Strategy
We aimed to capture all relevant interventions that alter early childhood growth outcomes. We
developed a life-course conceptual framework to guide the study, specifically to determine the
appropriate intervention domains at each life period (Figure 1). We identified relevant LMIC-based
trials by scanning prior systematic reviews and global health policy guidelines. This step formulated
the trial eligibility criteria in the form of PICOS (population, interventions, comparisons, outcomes,
and study design) summarized in Table 1.
For each life period, we implemented 2-way sensitivity searches whereby we first hand-
searched systematic reviews and trials highlighted in recent global health guidelines and key
maternal, newborn, and child health (MNCH) articles (eFigure 1 in the Supplement). We followed this
with a comprehensive search of interventions for all life periods published from database inception
up to August 14, 2018. We searched the MEDLINE, Embase, and Cochrane Central Register of
Controlled Trials databases, as well performing hand searches of review article bibliographies. Full
search terms and details of the electronic searches are provided in the eAppendix and eTables 2
through 7 in the Supplement. The full texts of identified English-language articles were assessed
independently by a paired group of 4 reviewers (J.J.H.P., M.L.F., R.M., and V.J.) using a standardized
data extraction and quality assessment form. Any disagreements were settled by a fifth
reviewer (K.T.).
Figure 1. Life-Course Conceptual Framework for Linear Growth Interventions
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The first 1000 days of life were separated into 3
periods because the growth determinants and
requirements for these periods differ greatly. The
conceptual framework is informed by the ecological
systems theory by Bronfenbrenner.21 Interventions
during pregnancy and childhood will have health and
social implications in adolescence and in adulthood.
This will in turn alter the health and social outcomes of
the next generation of society. This study was guided
by comprehensive literature reviews and network
meta-analyses and by the concepts in the figure.
WASH indicates water, sanitation, and hygiene.
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Study Selection, Data Extraction, andOutcomeMeasures
Trials related tomicronutrient supplementation, balanced energy protein or food supplementation,
deworming, maternal education/support that included breastfeeding strategies and psychosocial
support, WASH, and kangaroo care were included for data extraction if they reported preterm birth
(<37 gestational weeks), birth weight (continuous), and/or low birth weight (<2500 g) outcomes for
pregnancy; length for age (LAZ), proportion stunted (LAZ less than −2 SDs), height/length, and/or
head circumference for the EBF period; or HAZ and/or proportion stunted (HAZ less than −2 SDs) for
the CF period. Trials that did not meet all the PICOS criteria were excluded. This review article
presents the details and the results on the preterm birth, birth weight, LAZ, and HAZ; the details and
the results of kangaroo care and other classes of interventions’ magnitude of associations with low
birth weight, stunting, height/length, and head circumference will be published elsewhere.
Two reviewers (J.J.H.P. andM.L.F.) independently extracted the data into a standardized
spreadsheet (Excel; Microsoft) and categorized results corresponding to the PICOS criteria for each
of the systematic reviews. Cross-checking for consistency was conducted by other reviewers (L.D.
and K.T.). For each eligible article, we extracted study characteristics (eg, title, first author, year of
publication, country, intervention type, and intervention arm), participant information (eg, mother’s
age, gestational age, sex of child, and intervention duration), and outcomemeasures (eg, preterm
birth, birth weight, and LAZ/HAZ). In addition, 2 reviewers (J.J.H.P. and E.G.S.) assessed risk of bias in
the included RCTs using the Cochrane Collaboration’s tool for assessing risk of bias.22
Statistical Analysis
We applied Bayesian evidence synthesis models, as recommended by the National Institute for
Health and Care Excellence in their Technical Support Document 2 (NICE TSD2).23 For pregnancy, the
magnitudes of associations of interventions are measured using odds ratios (ORs) with associated
95% credible intervals (95% CrIs) for preterm birth andmean differences (MeanDiffs) with
Table 1. PICOS Criteria for Trial Selection
Criterion Pregnancy, All Trimesters
Exclusive Breastfeeding
Period, 0-6 mo
Complementary Feeding
Period, 6-24 mo
Population Pregnant women living in LMICs Newborn infants aged 0-6 mo
living in LMICs
Children aged 6-24 mo
living in LMICs
Interventions Micronutrient and calcium
supplementation to mother
Balanced energy protein (ie, food)
supplementation to mother
Deworming
Maternal education
Any WASH intervention
Micronutrient and calcium
supplementation to mother
or to infant
Balanced energy protein
supplementation to mother
Food supplementation or
fortification to infant
Deworming
Maternal and breastfeeding
education/support
Any WASH intervention
Kangaroo carea
Micronutrient and calcium
supplementation to children
Food supplementation to
children
Deworming
Maternal education/support
Any WASH intervention
Comparisons Placebo
Standard of care (if applicable)
No intervention
Any of the interventions listed
above as monotherapy or in
combination that can be used for
indirect comparison
Outcomes At least 1 of the following 3
outcomes:
Preterm birth (<37 gestational wk)
Low birth weight (<2500 g)a
Birth weight (continuous)
At least 1 of the following 4
outcomes:
LAZ z score
Proportion of stunted
(LAZ less than −2 SDs)a
Height/lengtha
Head circumferencea
At least 1 of the following 2
outcomes:
HAZ z score
Proportion of stunted (HAZ
less than −2 SDs)a
Study design Randomized clinical trial
Abbreviations: HAZ, height for age; LAZ, length for
age; LMICs, low-income andmiddle-income countries;
PICOS, population, interventions, comparisons,
outcomes, and study design; WASH, water, sanitation,
and hygiene.
a The details on the analyses and results of kangaroo
care and other interventions’ magnitude of
associations with low birth weight, stunting, height/
length, and head circumference will be published
elsewhere. Tomaintain external validity and prevent
inflation of findings, trials representing
subpopulations, such as infants born to HIV-positive
mothers and infants born preterm, with low birth
weight, with severe acute malnutrition, or with
preexisting health conditions, were excluded for all 3
life-period analyses.
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associated 95% CrIs for birth weight. For EBF and CF life periods, the interventions’ magnitudes of
associations with LAZ and HAZ are measured using MeanDiffs with associated 95% CrIs.
To allow for comparisons of interventions across multiple life periods, we calculated the
posterior probability for achieving a minimally clinically importance difference (MCID) for preterm
birth and birth weight (pregnancy), LAZ (EBF), and HAZ (CF) outcomes. Based on the
recommendations of clinical experts, we determined theMCID threshold of 15% for preterm birth
and 0.15 standardizedMeanDiff improvement (ie, improvement of 0.15 SD) for continuous outcomes
for the primary analysis. TheMCID for birth weight outcomewas calculated using theWHO Child
Growth Standards (1 SD equals 474 g).24 Accordingly, we defined theMCID threshold for birth weight
as follows: 474 g ×0.15 = 71.1 g. As sensitivity analyses, we considered the MCID thresholds of 10%
and 20% for preterm birth and 0.10 and 0.20 standardized MeanDiff improvement for LAZ, HAZ,
andmean birth weight (ie, 47.4 g and 94.8 g, respectively). These MCID thresholds have previously
been used in the sample size calculations of several MNCH trials.25-34
Because we anticipated heterogeneity between different trials, we used random-effects
models for our NMAs. We used empirically informative priors for the heterogeneity variance, as
suggested by Rhodes et al35 for LAZ/HAZ and by Turner et al36 for preterm birth outcome, to stabilize
the estimation of heterogeneity in the face of the low number of trials per comparison in the
network. We used noninformative priors for mean birth weight outcome. We considered different
random-effects model options with or without baseline adjustments or meta-regression based on
baseline characteristics (eg, age of children andmothers). Our model selection was informed by the
deviance information criterion (DIC) and the deviance-leverage plots that could help identify outliers
or lack of model fit. The final model selection was done according to recommendations of the
NICE TSD2.23
Across the 3 early-life periods, our primary analyses included both cluster and individually
randomized RCTs. Within the cluster trials included in our NMA, a mean value of intracluster
correlation coefficient (ICC) of 0.0505was reported,25-27,29-31,37-44 so we assumed a conservative
value of 0.05 to adjust for the clustering consequences of the cluster trials in our analyses. The ICC
was used to inflate variance accordingly for the continuous outcome and to down-adjust the sample
sizes and the number of cases for the dichotomous outcome, as recommended by Uhlmann et al.45
We conducted sensitivity analyses for each outcome by excluding cluster RCTs. We conducted NMAs
for each life period in a software program (R; The R Project for Statistical Computing) using the
R2WinBUGS 14 package.46,47 Full details of our statistical approaches, including inconsistency, are
provided in the eAppendix in the Supplement.
Results
Among 302061 participants comprised of 169 randomized clinical trials, the network meta-analyses
found several nutritional interventions that demonstrated greater association with improved birth
and growth outcomes compared with standard of care. For instance, compared with standard of
care, maternal supplements of multiple micronutrients (MMN) showed reduced odds for preterm
birth (OR, 0.54; 95% CrI, 0.27-0.97) and improvedmean birth weight (MeanDiff, 0.08 kg; 95% CrI,
0.00-0.17 kg) but not LAZ during EBF (MeanDiff, −0.02; 95% CrI, −0.18 to 0.14). Supplementing
infants and childrenwithMMN showed improved LAZ (MeanDiff, 0.20; 95%CrI, 0.03-0.35) and HAZ
(MeanDiff, 0.14; 95% CrI, 0.02-0.25). The study found that pregnancy interventions generally had
higher MCID probabilities than the interventions for the EBFor CF in the first 1000 days of life.
Our systematic search yielded publications that included 302061 participants, of which
205 867 were pregnant women, 32 320weremother-infant dyads, and 63 874were children aged 6
to 12months. The systematic search of databases and hand searching of bibliographies of published
review articles yielded 22 738 abstracts (eFigure 2 in the Supplement). Of these abstracts, 1072
studies underwent full-text review, resulting in 235 articles reporting on 169 trials (87 for pregnancy,
27 for EBF, and 68 for CF) that met our inclusion criteria. The participants were randomized to 461
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arms. This included 29 cluster RCTs that randomized 4207 clusters (182 421 participants) to 88
intervention arms. A list of the final included studies (eTables 8-10 in the Supplement), the excluded
studies (eTables 11-13 in the Supplement), the associated trial characteristics (eTables 14, 15, and 16
in the Supplement), and participant characteristics (eTables 17-19 in the Supplement) can be found
online. Studies were located predominantly in the following geographic regions: South East Asia
(n = 89), Africa (n = 72), and South America (n = 27). In all 3 life periods, micronutrient
supplementation (n = 133 of 169) was themost common intervention domain investigated (76 of 87
for pregnancy, 10 of 27 for EBF, and 47 of 68 for CF). A bias assessment was completed for all
included trials (eTable 20 in the Supplement). For all domains except “Blinding of participants and
personnel (performance bias),” more than 90% of studies had either low or unclear bias.
Interventions forWomenDuring Pregnancy
The network of evidence diagram for pregnancy interventions is shown in Figure 2A.We summarize
the results of several key interventions for this life period in Table 2, and the full results of our analysis
are shown in eFigures 3A, 3B, 5A, and 5B in the Supplement. Themodel diagnostics are provided in
eFigures 3C, 3D, 3E, and 3F in the Supplement. Compared with standard of care, MMN supplements
demonstrated reduced odds of preterm birth. No important differences in preterm birth were
observed for the other interventions.
For mean birth weight, the following resulted in modest improvements relative to standard of
care: iron, iron plus calcium, calcium plus vitamin D, zinc, iron plus folic acid (IFA) plus vitamin A,
MMN, a single dose of deworming plus iron, and 118 kcal (20 g) of lipid-based nutrient
supplementation (LNS 118kcal). No important differences were observed for the remaining
interventions for birth weight.
Interventions forMothers and Infants During EBF (0-6Months)
The network diagram of evidence for the EBF is shown in Figure 2B. The results of our NMA for key
interventions formothers and infants during EBF life period are listed in Table 2, and the full results of
our analysis are shown in eFigures 3G and 4C in the Supplement. Themodel diagnostic of the EBF
NMA is shown in eFigures 3H and 3I in the Supplement. Compared with standard of care,
supplementing mothers with MMN did not show improvements for LAZ, but supplementing infants
directly with MMN showed improvements in LAZ. No other interventions led to improvements.
Interventions for ChildrenDuring CF Period (6-24Months)
The network for the CF is shown in Figure 2C. The results regarding the key interventions for this life
period are summarized in Table 2 (with the full results shown in eFigure 3J and eFigure 4D in the
Supplement). Themodel diagnostic of the NMA for the CF is shown in eFigures 3K and 3L in the
Supplement. Micronutrient supplementations of IFA andMMN showed increased associations with
improvements in HAZ. Food supplements, deworming, maternal education, andWASH did not show
a positive association with HAZ.
Assessment of InterventionDomains Across the First 1000Days of Life
Posterior probabilities of key interventions being superior to standard of care by at least the
predefinedMCID for preterm birth, mean birth weight, LAZ, and HAZ are shown in Figure 3. The full
MCID results are available online (eFigure 5A-D and eFigure 6A-D in the Supplement). Among the
micronutrient supplements domain, several maternal micronutrient supplements during pregnancy
life period demonstrated high probabilities of achieving an MCID for preterm birth, and fewer
interventions demonstrated high probabilities of achieving anMCID for birth weight. For both
outcomes of preterm birth andmean birth weight, maternal supplements of zinc and iron plus
calcium showed highMCID probabilities. Other supplements, such as MMN, IFA, iron plus zinc, iron,
and folic acid, showed inconsistent associations.
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Figure 2. Overall Network Diagrams of Interventions for Pregnancy, Exclusive Breastfeeding Period, and Complementary Feeding Period Life Stages
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Similar to micronutrients, several balanced energy and protein supplements for pregnant
women demonstrated higher probabilities of achieving anMCID consequence for preterm birth than
mean birth weight, but their MCID probabilities were generally lower than those of the
micronutrients. Maternal supplements of unfortified LNS 118 kcal had higher MCID probabilities for
preterm birth and mean birth weight than fortified LNS 118-130 kcal, fortified LNS 372 kcal, and
fortified flour 750 kcal. Fortified local food 597-850 kcal showed higher MCID probability for preterm
birth, but its MCID probability for mean birth weight was low. Deworming and maternal education
interventions showed lowMCID probabilities.
After birth, interventions under all domains generally did not show highMCID probabilities for
either LAZ or HAZ. During the EBF period, maternal MMN and IFA supplements showed low MCID
probabilities for LAZ. Provision of MMN directly to infants during this life period showed a slightly
higher MCID probability. For the CF stage, IFA and MMN showed above-average MCID probabilities
for HAZ. All other interventions were associated with low probabilities for this life period.
Table 2. Random-Effects NetworkMeta-analysis Results of Selected Key Interventions Across the 3 Life Periodsa
Outcome
Pregnancy
Exclusive Breastfeeding
Period, LAZ, MeanDiff
Complementary Feeding
Period, HAZ, MeanDiff
Preterm Birth,
OR (95% CI)
Birth Weight,
MeanDiff (95% CI), kg
Micronutrients vs Standard of Care
MMN (maternal) 0.54 (0.27 to 0.97)b 0.08 (0.00 to 0.17)b −0.02 (−0.18 to 0.14)b NA
MMN (child) NA NA 0.20 (0.03 to 0.35) 0.14 (0.02 to 0.25)
Iron + folic acid 0.59 (0.30 to 1.07)b 0.05 (−0.04 to 0.13)b 0.05 (−0.15 to 0.23)b 0.18 (0.05 to 0.30)
Zinc 0.53 (0.28 to 0.93)b 0.12 (0.06 to 0.18)b 0.12 (−0.03 to 0.24) −0.02 (−0.08 to 0.04)
Iron + calcium 0.16 (0.03 to 0.87)b 0.15 (0.02 to 0.28)b NA NA
Iron + zinc 0.56 (0.28 to 1.05)b 0.08 (0.00 to 0.17)b NA −0.04 (−0.13 to 0.05)
Iron 0.55 (0.31 to 0.90)b 0.09 (0.03 to 0.15)b NA 0.05 (−0.04 to 0.15)
Folic acid 0.61 (0.30 to 1.13)b 0.05 (−0.03 to 0.14)b NA NA
Calcium 0.76 (0.56 to 0.98)b 0.03 (−0.01 to 0.07)b NA NA
Balanced Energy Protein or Food Supplements vs Standard of Care
LNS 118 kcal (20 g) 0.58 (0.27 to 1.14)b 0.11 (0.02 to 0.21)b NA −0.04 (−0.19 to 0.11)
Fortified LNS 118-130 kcal (20-25 g) 0.56 (0.25 to 1.16)b 0.09 (−0.02 to 0.20)b 0.08 (−0.13 to 0.29)b −0.03 (−0.11 to 0.04)
Fortified LNS 220-285 kcal (40-50 g) NA NA NA 0.01 (−0.09 to 0.07)
Fortified LNS 372 kcal (72 g) 0.64 (0.29 to 1.32)b 0.10 (−0.02 to 0.21)b NA NA
LNS 746 kcal 0.24 (0.04 to 1.09)b NA NA NA
Flour 270-340 kcal NA NA NA 0.05 (−0.08 to 0.19)
Fortified flour 750 kcal 0.25 (0.03 to 1.66)b 0.05 (−0.07 to 0.18)b NA NA
Local food 185-260 kcal NA NA NA 0.04 (−0.10 to 0.18)
Fortified local food 597-850 kcal NA 0.08 (−0.03 to 0.18)b NA NA
Formula 335 kcal NA NA 0.05 (−0.20 to 0.30) NA
Deworming, WASH Interventions, and Maternal Education vs Standard of Care
Deworming 1 dose 0.85 (0.21 to 3.23)b 0.02 (−0.02 to 0.07)b NA −0.01 (−0.13 to 0.10)
Maternal education NA 0.04 (−0.12 to 0.20)b 0.05 (−0.12 to 0.23)b −0.10 (−0.26 to 0.03)b
WASH NA NA NA −0.06 (−0.19 to 0.06)
WASH + fortified LNS 118 kcal (20 g) NA NA NA 0.02 (−0.10 to 0.14)
Abbreviations: HAZ, height for age; LAZ, length for age; LNS, lipid-based nutrient
supplements; MeanDiffs, mean differences; MMN, multiple micronutrients; NA, not
available; OR, odds ratio; WASH, water, sanitation, and hygiene.
a Each cell represents the estimated comparative result (ORs or MeanDiffs and their
respective 95% CIs) vs standard of care from the primary analysis that included both
cluster and noncluster randomized clinical trials.
b Interventions that were provided tomothers and those cells without this superscript
letter indicate interventions that were provided to children.
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Figure 3. Probability of Key Interventions Under the Domains ofMicronutrients, Balanced Energy Protein and
Food Supplements, Deworming, andMaternal Education, WithWater, Sanitation, and Hygiene (WASH) Being
Superior to Standard of Care by at Least the Minimal Clinically Importance Difference (MCID) Across the 3 Life
Stages
0
Probability of Being Superior to Standard of Care by at Least 
the MCID Across the 3 Life Stages
0.2 1.00.6 0.80.4
WASH + fortified
LNS 118 kcal
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Maternal
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Shown is the probability of interventions being
considered superior by anMCID vs standard of care
(SOC). TheMCID threshold is defined in the Statistical
Analysis subsection of the Methods section. These
selected interventions had comparative effect sizes (vs
SOC) of a promising magnitude. Full MCID probability
results are provided in the eAppendix in the
Supplement. CF indicates complementary feeding
period (6-24months); EBF, exclusive breastfeeding
period (0-6months); HAZ, height for age; IFA,
iron + folic acid; LAZ, length for age; LNS, lipid-based
nutrient supplements; and MMN, multiple
micronutrients.
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Sensitivity Analyses
For all of the 3 life periods, the results of the sensitivity analyses based on only individual RCTs were
generally similar to the primary analyses. The results from these sensitivity analyses can be found in
eFigure 4A to D and eFigure 6A to D in the Supplement. Because fewer studies were available, the
95% CrIs for many comparisons became wider. However, the magnitudes and directions of
associations remained stable. For instance, the micronutrient supplements that demonstrated
reducedORs in the primary analysis (eg, MMN, iron, calcium, zinc, and iron plus calcium) also showed
similar trends in the sensitivity analysis but with wider 95% CrIs.
Moreover, the sensitivity analyses with varying MCID thresholds generally showed similar
trends as the primary analyses. When a lower threshold was used for the analyses, the MCID
probabilities became larger for all interventions (eFigures 7A, 7C, 7E, and 7G in the Supplement), and
theMCID probabilities became lowerwith higherMCID thresholds (eFigures 7B, 7D, 7F, and 7H in the
Supplement). Across different life periods, the pregnancy interventions still showed higher MCID
probabilities with either lower and higher MCID thresholds than the interventions of the later
life periods.
Discussion
In this study, we sought to comprehensively acquire, assess, and synthesize evidence to better
understand themagnitude of associations between a range of interventions on birth and linear
growth outcomes for pregnant women, infants, and children living in LMICs. We conducted NMAs
(one for each early-life period) to evaluate the magnitude of associations with preventive
interventions under several domains, includingmicronutrients, balanced energy and protein and
food supplements, maternal education, deworming, andWASH.We found several interventions that
could improve birth outcomes and linear growth outcomes for infants and children living in LMICs.
TheMCID probabilities of interventions under the nutritional (micronutrient and food supplements)
domains were generally greater than those of other domains. We also found that themagnitude of
associations with interventions varies between different life periods. For instance, maternal
supplementation of MMN during pregnancy was shown to be superior to standard of care, but
provision of maternal MMN during the EBF period was not shown to be statistically superior to
standard of care. Larger MCID probabilities were demonstrated for pregnancy comparedwith the life
periods after birth, highlighting the importance of intervening early during the fetal growth.
Our results are largely comparable to previously published review articles in terms of the
precision of effect size estimates and trends of the associations.11,12,48 However, in our analysis on
preterm birth, we found an OR of 0.54 (95% CrI, 0.27-0.97) for MMN compared with standard of
care. This appears to disagreewith the findings of a recently published Cochrane review onMMN that
found a relative risk of 0.95 (95% CI, 0.90-1.01) for preterm birth.48 However, in that Cochrane
review, a pairwise comparison of MMNwasmade with “iron with or without folic acid,”48(p8) whereas
our NMA comparedMMNagainst IFA and iron alone separately. Our network analysis showed similar
associationswith preterm birth as the Cochrane review, withMMN showing anOR of 0.90 (95%CrI,
0.78-1.01) compared with IFA and an OR of 1.01 (95% CrI, 0.54-1.82) compared with iron.
Some of the differences between our analyses and the previously published review articles can
be attributed to the differences in PICOS criteria used to guide the study selection (eTable 1 in the
Supplement). For instance, in our analyses for the CF period, we excluded trials with children older
than 24months because the nutritional needs of these older children are considerably different than
those of the children in the CF period. Some of the other review articles also included studies that
were not RCTs (eg, quasi-randomized and nonrandomized studies). As well, we adjusted for the
clustering consequences of the cluster trials in our analyses, while other review articles that included
cluster trials did not always report details on ICC adjustment.
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Strengths and Limitations
A key strength of our review article is the use of a life-course perspective that enables critical insights
into the current evidence base, generating a better understanding of the consequences of these
interventions across key stages of the early-life trajectory. For instance, growth rates can vary
substantially across the early-life periods, with such variability being heavily influenced by
biochemical, genetic, and pathophysiological processes alongside external, environmental factors.49
Indeed, there is some evidence that infants who are low birth weight or premature may experience
a robust velocity of growth if appropriate management of nutrition is maintained.50 Therefore,
following the associations of stunting interventions across these 3 key stages is crucial to determining
the optimum timing for intervention implementation. In particular, our review article appears to
indicate that earlier interventions are more often associated with greater benefits.
Limitations include the lack of repeated trials of some interventions or domains and the lack of
long-term clinical trials across the different life periods from early trimester of pregnancy to the end
of the CF period. Few studies evaluated interventions across all 3 life periods26,30,43,51-55 or across 2
early-life periods.42,56-60 Consequently, the long-term association of interventions with improved
birth and linear growth could not be accounted for in our analysis. Further to this point was the
substantial heterogeneity observed in the interventions themselves, as well as the duration of the
interventions and the timing of outcome assessments, particularly during the EBF and CF.
In relation to the scope of the current evidence, the evidence base was limited pertaining to
maternal education, deworming, andWASH. A potential explanation could be the lack of focus on
such interventions because there are a number of associated design and resource challenges. These
include difficulties creating standardized interventions, heterogeneity in measuring baseline
maternal education and other socioeconomic status levels, as well as cost and human resource
limitations. The small number of studies reporting on these interventions may have had a role in the
less convincing results for these outcomes.
We opted to focus onmicro-level interventions after reviewing the bibliographies of existing
systematic reviews (eTable 1 in the Supplement) and keyMNCH articles12,61 because the RCT
evidence base for macro-level approaches (eg, family planning and vocational training) was limited.
However, we recognize the need for more investigation into these approaches to gain a better
understanding of the social processes that contribute to linear growth faltering.5
In addition, few interventions have been assessed across 2 or more life periods, and there is a
paucity of information on the consequences of combining interventions. While MMN is a
combination of nutritional interventions, the component interventions potentially driving the results
are, as yet, unknown. More trial research is needed to investigate the long-term and additive
consequences of individual components of interventions.
Generally, RCTs are known for being a costly, time and resource–intensive approach for
determining treatment effectiveness. Most trials herein used a conventional trial approach with a
fixed sample size design, where the assessment of effectiveness occurred only after the number of
participants recruited reached the calculated sample size target. However, it is important to point out
that the degree of clinical equipoise that could justify the initial trial design decreases as data
accumulate during the trial. Applying a conventional trial approach to investigate several treatments
across extended periods is often not efficient. While more clinical trials are needed to improve the
quality of evidence, future trials will also require more efficient clinical trial designs. To achieve the
40% reduction target set forth by the World Health Assembly62 to reduce the number of children
with stunted growth younger than 5 years by 2025, it is necessary and important to ensure that our
assessment of interventions is comprehensive and appropriate for different settings.
Conclusions
The findings of our study highlight the importance of intervening early to improve birth outcomes
and counter childhood stunting. Our findings suggest that nutritional interventions, micronutrients,
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and food supplements generally showed greater associations with improved outcomes than
interventions from other domains. Despite the numerous clinical trials that have already been
conducted, more research targeting less explored areas, such as maternal education andWASH,
appears to be needed. We believe that additional research that combines multiple intervention
domains will also prove valuable for critical issues in global child development.
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